What Happened?

If your money or your business touches China's tech sector, D.C. just drew a new line around where it can go. Congress enacted the Comprehensive Outbound Investment National Security Act (COINSA) of 2025, targeting U.S. capital going into China's semiconductor, artificial intelligence, and quantum information sectors. The Congressional Research Service (CRS), a nonpartisan research arm of Congress, published the report titled Regulation of U.S. Outbound Investment to China, on Oct. 1, examining COINSA as the first specific U.S. program to regulate these investments. The law covers not only China but also Cuba, Iran, North Korea, Russia, and Venezuela.

Why Does it Matter to Me?

U.S. capital flowing into China's semiconductor, artificial intelligence, and quantum information sectors could advance foreign military and surveillance capabilities, according to the Legis1 article on the law. American capital invested in the listed sectors could advance foreign military and surveillance capabilities.

The CRS report says the practical reach of the new restrictions will depend heavily on choices the U.S. Department of the Treasury has yet to make. Until Treasury sets those rules, investors and businesses face uncertainty about exactly which deals are off-limits.

Both Sides, Now

Some U.S. business groups have expressed support for the program's tailored approach, while also warning that foreign firms could fill any loss of U.S. market share in China that results from the restrictions.

Bloomberg reported on April 2, 2025, that branches of China's National Development and Reform Commission had been told to pause registration and approval for firms seeking to invest in the U.S., which the cited summary says shows that investment access can be affected by bilateral restrictions and retaliation. Critics argue that if U.S. investors pull back, competitors from other countries may capture those commercial opportunities instead.

The Trump administration is reviewing whether the existing program has sufficient controls to address national security threats, and a CRS report says its practical reach will depend heavily on choices Treasury has yet to make.

What Happens Next?

A separate bill, H.R. 9102, would expand COINSA's prohibited technologies to include biotechnology. The CRS report notes further expansion and congressional scrutiny of exemptions are possible. No vote on H.R. 9102 is scheduled, and the administration's ongoing review adds another variable to the timeline, according to Legis1 coverage of the law.

---

AllCiv makes it easy to stay politically informed and involved.

---

Spot something wrong? Report an issue with this article